article thumbnail

Medical Marijuana Offers Hope for Treatment of PTSD

FloridaMarijuana.net

A January 2018 Scientific American article titled “As Vets Demand Cannabis for PTSD, Science Races to Unlock Its Secrets” details a 2009 clinical trial in Canada which showed that the nighttime administration of THC reduced the frequency and intensity of nightmares in 72 percent of the 47 patients studied.”.

Treatment 182
article thumbnail

New Frontiers in the Law of Psychedelics

Cannabis Law Report

Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].

Law 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Former member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave Appoints Psychopharmacologist, Board-Certified Psychiatrist, And Licensed Physician, Bankole Johnson To Its Medical Advisory Board

Cannabis Law Report

He was also listed in “Best Doctors in America” in 2007, 2009, and 2010. We look forward to Dr. Johnson’s expertise as we expand our mental health analytical platform and enter clinical trials.” In 2019, Dr. Johnson received the R. ” About Ehave, Inc. Ehave, Inc.

article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. It became illegal in the US in 2009.

History 119
article thumbnail

Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”

TheAnswerPage

For example, most, if not all, states have legalized the use of medical marijuana to treat specific health conditions for which there is no or only poor quality clinical evidence of efficacy and safety. Since 2009, Dr. Fisher-Corn has served as Editor-in-Chief of TheAnswerPage.com.

article thumbnail

EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl

Cannabis Law Report

Freia (www.freiafarmaceutici.it) was founded in 2009 and is presently the only company in Italy and one of few in Europe, to have created and are marketing hemp based pharmaceutical products approved by the Italian Ministry of Health and licensed for sale throughout the EU. LGC has also appointed two members to Freia’s board of directors.

article thumbnail

Here’s what you need to know about cannabis research

The Cannigma

The highest quality form of scientific research, in terms of whether the results provide predictive power (which is what science is all about), is the placebo controlled, double blind, randomized clinical trial. Non-clinical research can help answer questions regarding safety and risk in very powerful ways.